NDRG2 and breast carcinoma: Liu et al. have analyzed mechanisms involved in downregulation of NDRG2 in 13 breast cancer cell lines and 21 paired breast cancer–normal tissue samples from patients, and they found that NDRG2 mRNA and protein levels were reduced in eight cell lines and five breast cancer samples, with the mechanism of downregulation being complex and dependent on cell type [26].